Gynaecomastia associated with combination antiretroviral therapy including protease inhibitors for human immunodeficiency virus infection

International Journal of STD and AIDS

Volumn 10, Issue 4, 1999, Pages 275-276

  Post, Jeffrey J ^a,b  

^a PRINCE OF WALES HOSPITAL   (Australia)

^b Albion Street Centre ^*  (Australia)

Author keywords

Antiretroviral therapy; Gynaecomastia; HIV protease inhibitors

Indexed keywords

ANTIRETROVIRUS AGENT; DIDANOSINE; LAMIVUDINE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; STAVUDINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; GYNECOMASTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL;

ANTI-HIV AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG THERAPY, COMBINATION; GYNECOMASTIA; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HOMOSEXUALITY, MALE; HUMANS; LAMIVUDINE; MALE; MIDDLE AGED; RITONAVIR; SAQUINAVIR; STAVUDINE;

EID: 0032945871     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462991913934     Document Type: Article

References (6)

1. 1 Herry I, Bernard L, de Truchis P, Perronne C. Hypertrophy of the breasts in a patient treated with indinavir. Clin Infect Dis 1997;25:937-8
2. 2 Lui A, Karter D, Turett G. Another case of breast hypertrophy in a patient treated with indinavir. Clin Infect Dis 1998;26:1482
3. 3 Toma L, Therrien R. Gynecomastia during indinavir antiretroviral therapy in HIV infection. AIDS 1998;12:681-2
4. 4 Viraben R, Aquilina C. Indinavir associated lipodystrophy. AIDS 1998;12:F37-F39
5. 5 Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-F58
6. 6 Braunstein GD. Gynecomastia. N Engl J Med 1993;328:490-5